Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cidara Therapeutics (CDTX) Non Operating Investment Income: 2018-2019

Historic Non Operating Investment Income for Cidara Therapeutics (CDTX) over the last 2 years, with Dec 2019 value amounting to $411,000.

  • Cidara Therapeutics' Non Operating Investment Income was N/A to $681,000 in Q2 2019 from the same period last year, while for Jun 2019 it was $5.4 million, marking a year-over-year change of. This contributed to the annual value of $411,000 for FY2019, which is 89.46% down from last year.
  • Latest data reveals that Cidara Therapeutics reported Non Operating Investment Income of $411,000 as of FY2019, which was down 89.46% from $3.9 million recorded in FY2018.
  • Cidara Therapeutics' Non Operating Investment Income's 5-year high stood at $3.9 million during FY2018, with a 5-year trough of $411,000 in FY2019.
  • Its 2-year average for Non Operating Investment Income is $2.2 million, with a median of $2.2 million in 2018.
  • Data for Cidara Therapeutics' Non Operating Investment Income shows a maximum YoY slumped of 89.46% (in 2019) over the last 5 years.
  • Over the past 2 years, Cidara Therapeutics' Non Operating Investment Income (Yearly) stood at $3.9 million in 2018, then crashed by 89.46% to $411,000 in 2019.